Research and Development

The Research and Development team at Acumen Pharmaceuticals is dedicated to the discovery and optimization of innovative therapies targeting amyloid-beta oligomers for Alzheimer's and other neurodegenerative diseases. Comprising a diverse group of scientific and clinical experts, the team conducts in-depth research, develops drug formulations, and manages clinical trials to bring safe and effective treatments from the lab to patients. Their collaborative efforts focus on advancing our understanding of disease biology while ensuring rigorous development processes that align with regulatory standards.